Summary: Rick Doblin, Executive Director of Multidisciplinary Association for Psychedelic Studies (MAPS) sat down with Alex Klokus, Founder & Managing Partner of Kyber Capital, at SALT New York for discussion on the potential breakthrough mental health treatments that psychedelics can offer.
Originally appearing here (Archived)